Metabolomics Market Benefits from Rising Life Science R&D Activities

San Francisco, California, January 25, 2018: A recent market research report by TMR Research presents a thorough analytical account of the global metabolomics market. The report is titled “Metabolomics Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025.” The report states that despite the nascent stage of development of this field of science, developments across it are expected to happen at a promising pace in the next few years as it provides a much detailed picture of the phenotype of tissues, cells, organelles, organs, and whole organisms compared to protein profile or RNA and DNA.

The report states that the market will significantly benefit from a vast rise in research and development activities in the life sciences sector across the globe. The rising prevalence of a number of chronic diseases and the rise in demand for innovative and more effective treatment methods are expected to have a positive impact on the rate of development of the global metabolomics market over the report’s forecast period.

The market has witnessed an unprecedented rise in investments from both private and government bodies in the recent years and has led to the introduction of efficient metabolomics. The market is being supported massively from the continuous rise in technological advancements and will benefit from increased focus of companies on exploiting the vast untapped growth opportunities in developing economies.

Owing to the rising level of competition, companies are putting increased emphasis on strategic collaborations with the view of expanding their consumer bases and product portfolios. Acquisitions of smaller regional players have also increased significantly in the past years as companies focus on emerging economies for sustained growth opportunities.

Geographically, the report covers the metabolomics market for North America, the Middle East and Africa, Asia Pacific, Europe, and Latin America. The report states that the market in North America, which presently holds the dominant position in the global market, is also expected to remain the dominant regional market over the forecast period owing to the highly conducive research and development scenario for the life sciences sector and a well-established healthcare infrastructure in the region. The early adoption of technologically advanced medical devices is also expected to work in favor of the regional market over the report’s forecast period.

The report states that the market in Asia Pacific will expand at the most promising pace in the global market over the forecast period. Factors such as the rising pool of geriatrics, which is a demographic that is more susceptible to a number of diseases, increased expenditure on healthcare, rising disposable incomes, and the rising demand for improved healthcare infrastructure are all working in favor of the regional market. The Asia Pacific metabolomics market is also expected to benefit massively from the thriving pharmaceutical sector, increased investment in research and development in the life sciences sector, and the increased focus on advancement of the region’s healthcare sector.

The report also includes a detailed overview of the competitive dynamics of the global metabolomics market. The report profiles some of the leading companies in the market and presents an overview of recent developments. Companies operating in the global metabolomics market profiled in the report include Biocrates Life Sciences AG, Thermo Fisher Scientific, Inc.,Shimadzu Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Human Metabolome Technologies Inc., Bruker Corporation, Danaher Corporation, LECO Corporation, Metabolon Inc., and Waters Corporation.

Get Sample Copy of this Report

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2063